Value-Based Care Can Do More
The Home Health Value-Based Purchasing Model (HHVBP) was a five-year project from the Center for Medicare & Medicaid Innovation designed to improve the quality and cost effectiveness of home health. In late 2021, the Centers for Medicare & Medicaid Services announced that it would be expanding the HHVBP nationwide.
EP11 How to Build a Snowball with Mike Chambers
The Blind Spot With Deb Seymour speaks with Precision’s Mike Chambers about sales performance. Imagine working for a company that has trust & culture at its core. Teams collaborate, ideas are tested without fear of failure and respect and engagement help bring people to the “game” with a 100% committed attitude.
Looking Forward to 2022, COVID-19 Will Continue to Impact Pharma in Myriad Ways
Moving into 2022, the COVID pandemic unfortunately continues to dominate headlines. However, it’s not all bad news. AIS Health spoke with a variety of industry experts, including Precision’s Cynthia Miller and Reta Mourad, about the myriad ways COVID-19 will continue to impact pharma this year and beyond.
New PBM players banking on drug pricing transparency for success
Two new pharmacy benefit managers (PBMs), the Cost Plus Drug Company and PBGH, are looking to promote drug pricing transparency, which larger PBMs have been reluctant to do. Precision’s Cynthia Miller and Reta Mourad discuss the companies’ markedly different business models to lower drug prices and the challenges that lie ahead.
Mandatory Value-based Care Payment Models on the Horizon
To get healthcare costs under control and “bend the cost curve,” the Centers for Medicare & Medicaid Services is moving from a volume-based reimbursement model to one based on value. To that end, the Center for Medicare & Medicaid Innovation has developed over a dozen new voluntary and mandatory value-based payment models.
Cancer Care in the Misinformation Age
While misinformation has plagued the public health field for decades, social media has amplified its spread. Both medical and public health leaders are beginning to develop strategies for this public health crisis. Precision’s Cynthia Miller lists three ways pharma companies can work with stakeholders to address cancer misinformation using evidence-based approaches.
HHS Rule Not Only Empowers Patients but Also Benefits Other Industry Stakeholders
As the use of real-world data in the health care system grows, a recent HHS rule giving patients electronic access to their data stands to have a huge impact on this area. Precision’s Dominic Galante weighs in on the 21st Century Cures Act, including a discussion of stakeholders that could benefit from the rule and the potential for innovations within the health care system.
Pfizer and Takeda deals put spotlight back on value-based pricing programs
Over the last decade, value-based reimbursement models have garnered a mountain of interest, but challenges in building a data infrastructure that can identify outcome metrics and logistics to dispense payments have largely relegated these models to anecdotal status. Recent deals by Pfizer and Takeda may indicate a step forward. Precision’s Ryan Cox weighs in on the evolving state of value based reimbursement models.
Treating Mental Health: Pay Now or Pay More Later
Mental health conditions, including depression and anxiety, have skyrocketed over the past two years during the pandemic. This mental health epidemic has sparked innovation among forward-looking leaders in the pharmaceutical and healthcare industries. Precision’s Cynthia Miller and Maureen Hennessey look at some of the newer innovations on the horizon as well as some of the policy changes in play that will accelerate transformation.
From Cold Prospect to Healthy Relationship w/ Mike Chambers
Listen as PRECISIONvalue’s Mike Chambers sits down with Ethan Beute, host of The Customer Experience Podcast, to discuss why relationship and responsiveness are at the center of customer experience, as well as other key insights regarding sales strategies.
